FindMyKOL
Clinical trialNCT04189419CompletedPhase 1/PHASE2Interventional

Safety and Efficacy of SCM-AGH in Patients With Moderate to Severe Acute Pancreatitis

SponsorSCM Lifescience Co., LTD.Enrollment36Pancreatitis, Acute
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study consists of two phases (Phase I and Phase IIa). Phase IIa will be conducted sequentially after the safety of SCM-AGH is secured in Phase I. * Phase I: Multicenter in Korea, Non-Randomized, Open-label, Single Arm, 3+3 design) for Severe Acute Pancreatitis * Phase II: Multicenter in Korea, Randomized, Double-blind, 2-arm, Placebo-controlled, Parallel arm for Moderate to Severe Acute Pancreatitis
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Soonchunhyang University Hosptial Bucheon

    Bucheon-si, Gyenggi-do, South Korea

  • Kyungpook National University Chilgok Hospital

    Daegu, South Korea

  • Dongguk University Ilsan Hospital

    Goyang-si, South Korea

  • Chonnam National University Medical School

    Gwangju, South Korea

  • Inha University Hospital

    Incheon, South Korea

  • Ajou University Hospital

    Suwon, South Korea

  • Wonju Severance Christian Hospital

    Wŏnju, South Korea

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

SCM-AGH
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
12 Aug 2019
Primary completion
14 Jan 2022
Completion
15 Mar 2022
Last update posted
8 Jun 2023
Registered enrollment
36
Registry id
NCT04189419
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.